XML 58 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense for Employees and Non-Employees
The following table presents total share-based compensation expense recorded (in thousands):
 Years Ended December 31,
 202320222021
Cost of revenues$2,256 $2,484 $1,621 
Research and development44,103 41,335 37,131 
Sales and marketing9,524 13,857 13,887 
General and administrative77,619 75,780 56,207 
Total share-based compensation expense$133,502 $133,456 $108,846 
Schedule of Assumptions Used to Determine Fair Value of ESPP
The following table presents the key assumptions used to determine the fair value of the awards:

Expected term (years)3.00
Expected volatility49.04 %
Expected dividends— %
Risk-free interest rate0.27 %
The following table presents the key assumptions used to determine the fair value of rights granted under the ESPP:
 Years Ended December 31,
 202320222021
Expected term (years)0.500.500.50
Expected volatility
55.79%-109.39%
70.37%-78.74%
47.02%-99.96%
Dividend yield0.00%0.00 %0.00 %
Risk-free interest rate
5.24%-5.41%
1.54%-4.54%
0.04%-0.07%
Weighted-average grant-date fair value per share$3.62 $8.71 $14.70 
Schedule of Restricted Stock Unit Activity
RSUs and PSUs Activity
 RSUs and PSUs Outstanding
 Number of RSUs and PSUs OutstandingWeighted Average Grant Date Fair Value
Balance at December 31, 20229,155,680 $36.03 
Granted6,283,841 14.58 
Released(3,637,801)35.32 
Forfeited(1,735,937)31.79 
Balance at December 31, 202310,065,783 $23.63 
Schedule of Stock Option Activity
Stock Option Activity
 
Stock Options Outstanding
 
Number of Stock Options Outstanding
Weighted-Average Exercise Price per ShareWeighted-Average Remaining Contractual Term in YearsAggregate Intrinsic Value
Balance at December 31, 2022326,258 $7.02 2.15$5,954,714 
Exercised(72,049) 
Forfeited(21,882) 
Balance at December 31, 2023232,327 $6.02 1.81$1,240,014